Company Analysis

Biofrontera Inc. (BFRI)

Nasdaq: BFRI · Pharmaceutical Preparations · Woburn, MA · filing with the SEC since 2021
Grade4.2
◀ Past 3.9● Present 4.1▶ Future 4.6
1 est.

Filings

302 filings since 2017 beside 65 insider forms · and emerging growth company · read from EDGAR on Nov 13, 2026
Due next and emerging growth company
10-Q Quarterly report for the quarter ending Sep 30, 2026Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end. by Nov 14, 2026
10-K Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends. by Mar 31, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. The proxy statement was last filed Apr 30, 2026.

Filings a yearinsider forms included
757946716531
202120222023202420252026

2026 counts to Nov 13, 2026.

Listing warning from its exchange (8-K item 3.01): 6 times in the last 36 months, the newest Jan 7, 2026.Officer or director change (8-K item 5.02): 2 times in the last 36 months, the newest Aug 11, 2025.Auditor change (8-K item 4.01): 1 time in the last 36 months, the newest Apr 18, 2025.SEC letters: 8 in the last 36 months, the newest Dec 17, 2025.
Insider forms 65

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Nov 13, 2026 SCHEDULE 13G/A Large holder update, amended
Nov 13, 2026 8-K items 2.02, 9.01 Results released · Current report
Oct 30, 2026 25-NSE Delisting notice from the exchange
Sep 14, 2026 8-K items 8.01, 9.01 Other event · Current report
Aug 13, 2026 10-Q Quarterly report Jun 30, 2026
Aug 13, 2026 8-K items 2.02, 9.01 Results released · Current report
Aug 12, 2026 SCHEDULE 13G/A Large holder update, amended
Jul 22, 2026 S-8 Employee stock plan registration
Jul 22, 2026 10-K/A Annual report, amended Dec 31, 2025
Jun 17, 2026 8-K item 5.07 Shareholder vote · Current report Jun 11, 2026
May 14, 2026 10-Q Quarterly report Mar 31, 2026
May 14, 2026 8-K items 2.02, 9.01 Results released · Current report
Apr 30, 2026 DEF 14A Proxy statement
Mar 19, 2026 10-K Annual report Dec 31, 2025
Mar 19, 2026 8-K items 2.02, 9.01 Results released · Current report
Mar 9, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Feb 26, 2026 8-K items 8.01, 9.01 Other event · Current report Feb 23, 2026
Feb 11, 2026 SCHEDULE 13G/A Large holder update, amended
Feb 9, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Jan 28, 2026 SCHEDULE 13G/A Large holder update, amended
Jan 13, 2026 8-K items 2.02, 9.01 Results released · Current report
Jan 7, 2026 8-K item 3.01 Listing warning from its exchange · Current report Dec 31, 2025
Dec 19, 2025 EFFECT Registration effective
Dec 17, 2025 CORRESP Reply to the SEC
Dec 5, 2025 S-1 Listing registration
Nov 13, 2025 8-K items 2.02, 9.01 Results released · Current report
Nov 12, 2025 SCHEDULE 13G/A Large holder update, amended
Nov 12, 2025 10-Q Quarterly report Sep 30, 2025
Nov 10, 2025 8-K item 8.01 Other event · Current report Nov 4, 2025
Nov 7, 2025 8-K items 1.01, 2.01, 7.01, 9.01 Major agreement signed; Purchase or sale of a business completed; Investor disclosure (Regulation FD) · Current report Nov 6, 2025
Oct 24, 2025 8-K items 1.01, 2.01, 3.02, 8.01, 9.01 Major agreement signed; Purchase or sale of a business completed; Shares sold without registration; Other event · Current report Oct 20, 2025
Oct 23, 2025 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Sep 19, 2025 8-K item 5.07 Shareholder vote · Current report Sep 16, 2025
Sep 19, 2025 SCHEDULE 13D/A Activist holder update, amended
Aug 19, 2025 EFFECT Registration effective
Aug 15, 2025 CORRESP Reply to the SEC
Aug 13, 2025 S-1/A Listing registration, amended
Aug 13, 2025 8-K items 2.02, 9.01 Results released · Current report
Aug 13, 2025 10-Q Quarterly report Jun 30, 2025
Aug 11, 2025 8-K items 5.02, 7.01, 9.01 Officer or director change; Investor disclosure (Regulation FD) · Current report
40 of 302 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton BFRI · research, not advice